Alterity Therapeutics Limited | PRAN - Cash And Equivalent


Alterity Therapeutics Limited reported AUD15.77M in Cash and Equivalent for its fiscal semester ending in June of 2023.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Arca Biopharma USD 91.25M 25.86M Sep/2025
aTyr Pharma USD 6.15M 11.07M Sep/2025
Bio Path 13.65M 3.37M Sep/2022
Brainstorm Cell Therapeutics USD 5K 819K Sep/2025
Capricor Therapeutics USD 19.51M 3.73M Sep/2025
Cara Therapeutics USD 20.65M 13.57M Jun/2025
CSL USD 2.16B 633M Jun/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Immunic USD 35.13M 20.18M Sep/2025
Infinity Pharmaceuticals USD 17.75M 7.99M Jun/2023
Insmed USD 510.44M 175.68M Dec/2025
Minerva Neurosciences USD 12.29M 2.96M Sep/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
TherapeuticsMD 523K 89K Jun/2024